|
HNRNPAB expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.95269997130765E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.032810E-04 |
| Normal-vs-Stage2 |
2.635000E-03 |
| Normal-vs-Stage3 |
1.0680999973367E-08 |
| Normal-vs-Stage4 |
7.76168018745693E-12 |
| Stage1-vs-Stage2 |
5.650800E-01 |
| Stage1-vs-Stage3 |
2.382100E-03 |
| Stage1-vs-Stage4 |
3.00489999993658E-07 |
| Stage2-vs-Stage3 |
1.392430E-01 |
| Stage2-vs-Stage4 |
2.696200E-03 |
| Stage3-vs-Stage4 |
4.554400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.52189999491625E-08 |
| Normal-vs-AfricanAmerican |
2.633000E-04 |
| Normal-vs-Asian |
3.253600E-01 |
| Caucasian-vs-AfricanAmerican |
6.709200E-01 |
| Caucasian-vs-Asian |
8.717800E-01 |
| AfricanAmerican-vs-Asian |
7.837800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.28429999973956E-07 |
| Normal-vs-Female |
2.05100003647374E-09 |
| Male-vs-Female |
4.960400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.773640E-02 |
| Normal-vs-Age(41-60Yrs) |
5.08940000032432E-07 |
| Normal-vs-Age(61-80Yrs) |
2.31679999629364E-08 |
| Normal-vs-Age(81-100Yrs) |
2.696600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.904600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.322000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.296000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.217000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.334600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.028800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.558000E-01 |
| Normal-vs-Grade 2 |
2.36590000000092E-05 |
| Normal-vs-Grade 3 |
2.00469999489528E-08 |
| Normal-vs-Grade 4 |
6.2613247919785E-12 |
| Grade 1-vs-Grade 2 |
3.432800E-01 |
| Grade 1-vs-Grade 3 |
1.249190E-01 |
| Grade 1-vs-Grade 4 |
3.697800E-03 |
| Grade 2-vs-Grade 3 |
6.467700E-02 |
| Grade 2-vs-Grade 4 |
2.18349999999701E-05 |
| Grade 3-vs-Grade 4 |
5.921900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.820770E-04 |
| Normal-vs-ccB subtype |
1.15740000028453E-07 |
| ccA subtype-vs-ccB subtype |
3.152100E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.56930000000588E-07 |
| Normal-vs-N1 |
4.563200E-03 |
| N0-vs-N1 |
1.732640E-01 |
|
|
